ONWARD Medical’s ARC-EX System Recognized by TIME
ONWARD Medical N.V. (EURONEXT: ONWD), a pioneering medical technology company, has achieved a remarkable honor with its investigational ARC-EX System being named one of TIME's Best Inventions. This recognition highlights the groundbreaking potential of their therapy to restore independence and function in those affected by spinal cord injuries (SCI).
Significance of the ARC-EX System
The ARC-EX System exemplifies innovation aimed at significantly aiding individuals with spinal cord injuries, which can profoundly impact their quality of life. Dave Marver, the CEO of ONWARD Medical, expressed gratitude for this recognition, emphasizing the system’s potential to change the lives of many. With spinal cord injuries often altering the course of lives drastically, marver conveyed hope that the ARC-EX Therapy is just the beginning of transformative therapies from ONWARD Medical.
Details of the TIME Selection Process
TIME's annual list, which showcases 200 innovative solutions, employed a rigorous selection process. Nominations were gathered from editors and correspondents around the globe, focusing on breakthroughs in health care, artificial intelligence, and renewable energy. Each entry was assessed on originality, effectiveness, ambition, and potential impact on society.
Public Awareness and Cultural Context
This esteemed recognition comes at a time when awareness about spinal cord injuries is rising, partly due to a major feature film drawing attention to the challenges faced by those affected. The importance of the ARC-EX System is underscored by testimonials from psychologists and medical professionals who work closely with patients battling these injuries.
Practical Implications of ARC-EX Therapy for Patients
Dr. Chet Moritz, a professor of Rehabilitation Medicine, highlighted the life-changing implications of the ARC-EX System. Many patients report the ability to perform tasks they once thought impossible, such as brushing their teeth or holding a cup. The recovery of hand function paves the way for independence, allowing people to return to everyday activities and family life without external assistance.
Clinical Evidence Supporting the Technology
A significant advancement that further validates ONWARD Medical’s efforts is the recent publication of findings from the Up-LIFT pivotal trial in Nature Medicine. This study showed marked improvements in upper limb strength and function among individuals with spinal cord injuries. Following this success, ONWARD Medical has moved forward with regulatory applications to the FDA to make the ARC-EX System available in the United States.
Impact on the Global Spinal Injury Community
Globally, spinal cord injury affects around seven million people, and in the U.S. alone, approximately 300,000 people endure these injuries. The study indexed nearly 90% of participants experiencing improved functionality. They noted that restoring hand and arm abilities often becomes the foremost desire in their rehabilitation journey.
Future Directions for ONWARD Medical
As ONWARD Medical looks to the future, it aims to expand its reach in developing solutions tailored for the spinal cord injury community. Their commitment includes not just providing therapies like ARC-EX but also engaging in ongoing clinical trials exploring innovative modalities of treatment.
Conclusion: A Step Towards Independence
ONWARD Medical’s recognition from TIME represents a significant milestone in the development of therapeutic technologies for spinal cord injuries. Their commitment to addressing the needs of individuals with movement disabilities is commendable and continues to inspire hope for a more independent future.
Frequently Asked Questions
What is the ARC-EX System?
The ARC-EX System is an investigational medical device designed to restore movement and function in individuals with spinal cord injuries.
Why was the ARC-EX System recognized by TIME?
TIME recognized the ARC-EX System for its potential to transform the lives of those suffering from spinal cord injury through innovative therapeutic applications.
How does the ARC-EX Therapy work?
ARC-EX Therapy involves targeted spinal cord stimulation aimed at improving upper limb function in individuals with spinal cord injuries.
What are the implications of the Up-LIFT trial results?
The Up-LIFT trial results demonstrated significant improvements in upper limb strength and functionality for participants receiving ARC-EX Therapy.
What is ONWARD Medical's future vision?
ONWARD Medical aims to continue developing innovative solutions that restore movement, function, and independence for individuals living with spinal cord injuries.
